JW중외제약

001060KOSPI의약품 제조업

53.7 / 100

Reference Date: 2026-07-24

Financial Score23.5 / 40

News Sentiment16.2 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but Operating Profit is on a declining trend. Declined 7.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JW Chungwa Pharmaceutical focuses on the research, development, manufacturing, and sales of pharmaceuticals, leveraging a strong pipeline of original drugs such as Rivaro and Winnerf, along with a global R&D network. The company offers a diverse range of specialty and over-the-counter medications, as well as healthcare products, maintaining a competitive edge in both domestic and international markets.

Number of Employees

1,106people

Average Salary

64.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.51Industry Average 11.235.0Point

In line with industry avg

PBR

1.52Industry Average 0.811.0Point

1.9x industry avg (risky)

ROE

17.60Industry Average 4.017.0Point

4.4x industry avg (excellent)

Debt Ratio

7.24Industry Average 12.435.0Point

Lower than industry avg (good)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.9% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼1.6% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 18.4% (improving, 3yr)

Detailed News Sentiment

26 totalPositive 12Neutral 14Negative 0Average Sentiment Score 64.8

Neutral
'경기 편하G버스' 동탄∼판교 등 5개 신규 노선 추진
신규 광역버스 노선 확장 계획 발표로 교통 편의성 향상 기대되나, JW중외제약과 직접적인 연관성은 없음.
Positive
주레바논대사관, 레바논에 한국산 필수의약품 전달
JW중외제약의 필수 의약품 수출로 인해 중동 지역의 의료 지원 강화, 기업 이미지 향상 기대.
Positive
JW중외제약, 혈액종양 치료 임상 전략 공유
JW중외제약의 혈액종양 치료 임상 전략 공유 심포지엄 개최로 인해 신약 개발 및 임상 진행에 대한 긍정적 기대감 증가.

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 24,100Won52-week high 39,05052-week low 20,950

1-month return1.0Point

1m -7.13% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-07-02